Sectors
July
TPG wades into in Trevi's $25m cash fountain
TPG Biotech has now invest almost $28m in the skin disorder specialist, which will use the cash to advance clinical trials for its lead product.
Jun 4, 2014
Other News
No posts to show.
Editor's Picks
No posts to show.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2023 Mawsonia Ltd. All rights reserved.
test reg